Literature DB >> 10027374

No survival benefit from combined pancreaticosplenectomy and total gastrectomy for gastric cancer.

K Kitamura1, S Nishida, D Ichikawa, H Taniguchi, A Hagiwara, T Yamaguchi, K Sawai.   

Abstract

BACKGROUND: It remains unknown whether extended surgery improves the survival rate of patients with gastric cancer. This study was a review of combined pancreaticosplenectomy with total gastrectomy for gastric cancer.
METHODS: The clinicopathological details of 190 patients who underwent combined pancreaticosplenectomy with total gastrectomy between 1969 and 1996 were compared retrospectively with those of 206 patients who underwent total gastrectomy with splenectomy alone.
RESULTS: There was no statistical difference in the survival rate when pancreaticosplenectomy was added to total gastrectomy. The mortality rate was similar, but the morbidity rate was higher in patients who had pancreaticosplenectomy. Six patients who had direct pancreatic invasion and two thought to have involved lymph nodes along the splenic artery survived for more than 5 years after operation. In the latter group, the metastatic lymph nodes along the splenic artery could have been resected without pancreatectomy.
CONCLUSION: Since a combined pancreaticosplenectomy adds no survival advantage to total gastrectomy for gastric cancer, this procedure should no longer be regarded as routine.

Entities:  

Mesh:

Year:  1999        PMID: 10027374     DOI: 10.1046/j.1365-2168.1999.00967.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  23 in total

1.  Evaluation of modified Estimation of Physiologic Ability and Surgical Stress in gastric carcinoma surgery.

Authors:  Yoshio Haga; Yasuo Wada; Hitoshi Takeuchi; Koji Ikejiri; Masakazu Ikenaga; Osamu Kimura
Journal:  Gastric Cancer       Date:  2011-05-03       Impact factor: 7.370

Review 2.  An evidence-based review of the surgical treatment of gastric adenocarcinoma.

Authors:  Ugwuji N Maduekwe; Sam S Yoon
Journal:  J Gastrointest Surg       Date:  2011-03-12       Impact factor: 3.452

3.  Value of splenectomy in patients with Siewert type II adenocarcinoma of the esophagogastric junction.

Authors:  Hironobu Goto; Masanori Tokunaga; Norihiko Sugisawa; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masahiro Niihara; Yasuhiro Tsubosa; Masanori Terashima
Journal:  Gastric Cancer       Date:  2012-11-18       Impact factor: 7.370

4.  Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection.

Authors:  Yoshihiro Kakeji; Manabu Yamamoto; Shuhei Ito; Masahiko Sugiyama; Akinori Egashira; Hiroshi Saeki; Masaru Morita; Yoshihisa Sakaguchi; Yasushi Toh; Yoshihiko Maehara
Journal:  Surg Today       Date:  2012-01-14       Impact factor: 2.549

Review 5.  Surgical management of esophagogastric junction tumors.

Authors:  Burkhard H A von Rahden; Hubert J Stein; J Rüdiger Siewert
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

6.  Effectiveness and safety of splenectomy for gastric carcinoma: a meta-analysis.

Authors:  Kun Yang; Xin-Zu Chen; Jian-Kun Hu; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

7.  Gastric cancer.

Authors:  Henk H Hartgrink; Edwin P M Jansen; Nicole C T van Grieken; Cornelis J H van de Velde
Journal:  Lancet       Date:  2009-07-20       Impact factor: 79.321

8.  Treatment results of curative gastric resection from a specialist Australian unit: low volume with satisfactory outcomes.

Authors:  Iain G Thomson; David C Gotley; Andrew P Barbour; Ian Martin; Neil Jayasuria; Janine Thomas; Bernard M Smithers
Journal:  Gastric Cancer       Date:  2013-03-09       Impact factor: 7.370

9.  New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma.

Authors:  Ugwuji N Maduekwe; Gregory Y Lauwers; Carlos Fernandez-Del-Castillo; David L Berger; Charles M Ferguson; David W Rattner; Sam S Yoon
Journal:  Ann Surg Oncol       Date:  2010-01-23       Impact factor: 5.344

Review 10.  Adjuvant treatment for gastric cancer: chemotherapy versus radiation.

Authors:  Noman Ashraf; Sarah Hoffe; Richard Kim
Journal:  Oncologist       Date:  2013-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.